Unknown

Dataset Information

0

(D620N) VPS35 causes the impairment of Wnt/?-catenin signaling cascade and mitochondrial dysfunction in a PARK17 knockin mouse model.


ABSTRACT: Patients with familial type 17 of Parkinson's disease (PARK17) manifest autosomal dominant pattern and late-onset parkinsonian syndromes. Heterozygous (D620N) mutation of vacuolar protein sorting 35 (VPS35) is genetic cause of PARK17. We prepared heterozygous VPS35D620N/+ knockin mouse, which is an ideal animal model of (D620N) VPS35-induced autosomal dominant PARK17. Late-onset loss of substantia nigra pars compacta (SNpc) dopaminergic (DAergic) neurons and motor deficits of Parkinson's disease were found in 16-month-old VPS35D620N/+ mice. Normal function of VPS35-containing retromer is needed for activity of Wnt/?-catenin cascade, which participates in protection and survival of SNpc DAergic neurons. It was hypothesized that (D620N) VPS35 mutation causes the malfunction of VPS35 and resulting impaired activity of Wnt/?-catenin pathway. Protein levels of Wnt1 and nuclear ?-catenin were reduced in SN of 16-month-old VPS35D620N/+ knockin mice. Downregulated protein expression of survivin, which is a target gene of nuclear ?-catenin, and upregulated protein levels of active caspase-8 and active caspase-9 were observed in SN of VPS35D620N/+ mice at age of 16 months. VPS35 is involved in controlling morphology and function of mitochondria. Impaired function of VPS35 caused by (D620N) mutation could lead to abnormal morphology and malfunction of mitochondria. A significant decrease in mitochondrial size and resulting mitochondrial fragmentation was found in tyrosine hydroxylase-positive and neuromelanin-positive SNpc DAergic neurons of 16-month-old VPS35D620N/+ mice. Mitochondrial complex I activity or complex IV activity was reduced in SN of 16-month-old VPS35D620N/+ mice. Increased level of mitochondrial ROS and oxidative stress were found in SN of 16-month-old VPS35D620N/+ mice. Levels of cytosolic cytochrome c and active caspase-3 were increased in SN of VPS35D620N/+ mice aged 16 months. Our results suggest that PARK17 mutant (D620N) VPS35 impairs activity of Wnt/?-catenin signaling pathway and causes abnormal morphology and dysfunction of mitochondria, which could lead to neurodegeneration of SNpc DAergic cells.

SUBMITTER: Chiu CC 

PROVIDER: S-EPMC7705022 | biostudies-literature | 2020 Nov

REPOSITORIES: biostudies-literature

altmetric image

Publications

(D620N) VPS35 causes the impairment of Wnt/β-catenin signaling cascade and mitochondrial dysfunction in a PARK17 knockin mouse model.

Chiu Ching-Chi CC   Weng Yi-Hsin YH   Huang Ying-Zu YZ   Chen Rou-Shayn RS   Liu Yu-Chuan YC   Yeh Tu-Hsueh TH   Lu Chin-Song CS   Lin Yan-Wei YW   Chen Yu-Jie YJ   Hsu Chia-Chen CC   Chiu Chi-Han CH   Wang Yu-Ting YT   Chen Wan-Shia WS   Liu Shu-Yu SY   Wang Hung-Li HL  

Cell death & disease 20201130 11


Patients with familial type 17 of Parkinson's disease (PARK17) manifest autosomal dominant pattern and late-onset parkinsonian syndromes. Heterozygous (D620N) mutation of vacuolar protein sorting 35 (VPS35) is genetic cause of PARK17. We prepared heterozygous VPS35<sup>D620N/+</sup> knockin mouse, which is an ideal animal model of (D620N) VPS35-induced autosomal dominant PARK17. Late-onset loss of substantia nigra pars compacta (SNpc) dopaminergic (DAergic) neurons and motor deficits of Parkinso  ...[more]

Similar Datasets

| S-EPMC7390708 | biostudies-literature
| S-EPMC6431187 | biostudies-literature
| S-EPMC7542911 | biostudies-literature
| S-EPMC4826611 | biostudies-literature
2021-07-20 | GSE149585 | GEO
| S-EPMC8048506 | biostudies-literature
| S-EPMC10848721 | biostudies-literature
| S-EPMC7706192 | biostudies-literature
| S-EPMC10903469 | biostudies-literature
2018-07-11 | GSE116900 | GEO